Veracyte, Inc. IPO Research Information

Veracyte, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Veracyte, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Veracyte, Inc.	VCYT - NASDAQ	$13.00-$15.00	$13.00	$13.00	5 million	10/30/2013
Underwriter(s): Morgan Stanley, Leerink Swann
Co-Manager(s): William Blair, Cowen & Co.
Industry: Health Care
Filing(s): Filed 2013-09-20

Veracyte, Inc. Quote & Chart - Click for current quote - VCYT

About Veracyte, Inc. (adapted from Veracyte, Inc. prospectus):
They are a diagnostics company pioneering the field of molecular cytology to improve patient outcomes and lower healthcare costs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "VCYT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.